Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PRT13722 |
| Trade Name | |
| Synonyms | PRT 13722|PRT-13722 |
| Drug Descriptions |
PRT13722 is a selective KAT6A degrader, which potentially inhibits tumor growth (Cancer Res (2026) 86 (7_Supplement): 5793). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Abemaciclib + Fulvestrant + PRT13722 | Abemaciclib Fulvestrant PRT13722 | 0 | 1 |
| Fulvestrant + PRT13722 | Fulvestrant PRT13722 | 0 | 1 |
| Imlunestrant + PRT13722 | Imlunestrant PRT13722 | 0 | 1 |
| PRT13722 | PRT13722 | 0 | 1 |